FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

What is Mohs micrographic surgery? 8 FAQs about Mohs

2.

Providing essential cancer care to rural communities

3.

Despite reports of hundreds of cancer cases, carcinogens have been discovered at nuclear missile sites in Montana.

4.

Children with cancer experience much less pain at home when using a pain monitoring app.

5.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot